Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial
Top Cited Papers
- 1 August 2010
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 376 (9741), 615-623
- https://doi.org/10.1016/s0140-6736(10)60755-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trialThe Lancet, 2010
- Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control studyBMJ, 2010
- Oral Rotavirus Vaccines: How Well Will They Work Where They Are Needed Most?The Journal of Infectious Diseases, 2009
- Rotavirus Vaccines for Infants in Developing Countries in Africa and Asia: Considerations from a World Health Organization–Sponsored ConsultationThe Journal of Infectious Diseases, 2009
- Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled studyVaccine, 2009
- Association Between Pentavalent Rotavirus Vaccine and Severe Rotavirus Diarrhea Among Children in NicaraguaJAMA, 2009
- Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of ageVaccine, 2009
- Concomitant Use of the Oral Pentavalent Human-Bovine Reassortant Rotavirus Vaccine and Oral Poliovirus VaccineThe Pediatric Infectious Disease Journal, 2008
- Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infantsVaccine, 2006
- Exact power and sample size for vaccine efficacy studiesCommunications in Statistics - Theory and Methods, 1998